NO175619C - Fremgangsmåte ved fremstilling av kontrollerte frigjöringsformuleringer av tetracyklinforbindelser - Google Patents

Fremgangsmåte ved fremstilling av kontrollerte frigjöringsformuleringer av tetracyklinforbindelser

Info

Publication number
NO175619C
NO175619C NO884408A NO884408A NO175619C NO 175619 C NO175619 C NO 175619C NO 884408 A NO884408 A NO 884408A NO 884408 A NO884408 A NO 884408A NO 175619 C NO175619 C NO 175619C
Authority
NO
Norway
Prior art keywords
preparation
controlled release
release formulations
tetracycline compounds
tetracycline
Prior art date
Application number
NO884408A
Other languages
English (en)
Other versions
NO175619B (no
NO884408D0 (no
NO884408L (no
Inventor
Jr Joseph James Valorose
Raymond J Biehl
Nitin V Sheth
Walter A Strathy
Michael Kay Doelling
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22303124&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO175619(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO884408D0 publication Critical patent/NO884408D0/no
Publication of NO884408L publication Critical patent/NO884408L/no
Publication of NO175619B publication Critical patent/NO175619B/no
Publication of NO175619C publication Critical patent/NO175619C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO884408A 1987-10-06 1988-10-05 Fremgangsmåte ved fremstilling av kontrollerte frigjöringsformuleringer av tetracyklinforbindelser NO175619C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/104,917 US4837030A (en) 1987-10-06 1987-10-06 Novel controlled release formulations of tetracycline compounds

Publications (4)

Publication Number Publication Date
NO884408D0 NO884408D0 (no) 1988-10-05
NO884408L NO884408L (no) 1989-04-07
NO175619B NO175619B (no) 1994-08-01
NO175619C true NO175619C (no) 1994-11-09

Family

ID=22303124

Family Applications (1)

Application Number Title Priority Date Filing Date
NO884408A NO175619C (no) 1987-10-06 1988-10-05 Fremgangsmåte ved fremstilling av kontrollerte frigjöringsformuleringer av tetracyklinforbindelser

Country Status (24)

Country Link
US (1) US4837030A (no)
EP (1) EP0310814B1 (no)
JP (1) JP2771189B2 (no)
KR (1) KR970007902B1 (no)
AR (1) AR243077A1 (no)
AT (1) ATE120957T1 (no)
AU (1) AU609525B2 (no)
CA (1) CA1338439C (no)
CZ (1) CZ279809B6 (no)
DE (1) DE3853566T2 (no)
DK (1) DK175578B1 (no)
ES (1) ES2070837T3 (no)
FI (1) FI97862C (no)
GR (1) GR3015767T3 (no)
HK (1) HK1000313A1 (no)
HU (1) HU202110B (no)
IL (1) IL87699A (no)
NO (1) NO175619C (no)
NZ (1) NZ226396A (no)
PH (1) PH27236A (no)
PL (1) PL275089A1 (no)
PT (1) PT88664B (no)
SK (1) SK278567B6 (no)
ZA (1) ZA887478B (no)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3887179T2 (de) * 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
US5211958A (en) * 1987-11-30 1993-05-18 Gist-Brocades, N.V. Pharmaceutical composition and process for its preparation
US5277916A (en) * 1988-02-01 1994-01-11 F. H. Faulding & Co., Ltd. Tetracycline dosage form
DE68916983T2 (de) * 1988-02-25 1995-01-19 Yamanouchi Europ Bv Verfahren zur Herstellung eines pharmazeutischen Granulats.
EP0418597A3 (en) * 1989-09-21 1991-11-27 American Cyanamid Company Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form
IL95423A (en) * 1989-09-21 1994-11-11 American Cyanamid Co Pulse system for delivery of minocycline once daily
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5460825A (en) * 1990-05-23 1995-10-24 Mcneil-Ppc, Inc. Taste mask coatings for preparing chewable pharmaceutical tablets
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
US5494903A (en) 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
USRE40183E1 (en) 1991-10-04 2008-03-25 Wyeth Holdings Corporation 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
AU663146B2 (en) * 1991-12-30 1995-09-28 R.P. Scherer Technologies, Inc. Microcrystalline cellulose spheronization composition
US5262173A (en) * 1992-03-02 1993-11-16 American Cyanamid Company Pulsatile once-a-day delivery systems for minocycline
CA2093282C (en) * 1992-05-04 1999-01-12 Tibor Sipos Intraoral medicament-releasing device
US5614223A (en) * 1992-05-04 1997-03-25 Digestive Care Inc. Intraoral medicament-releasing device
US6224911B1 (en) * 1993-03-16 2001-05-01 Syntex (U.S.A.) Llc Process for the preparation of enteric coated pharmaceutical dosage forms
US5536507A (en) * 1994-06-24 1996-07-16 Bristol-Myers Squibb Company Colonic drug delivery system
US20060067999A1 (en) * 1996-03-25 2006-03-30 Wyeth Extended release formulation
US20030215507A1 (en) * 1996-03-25 2003-11-20 Wyeth Extended release formulation
US6230052B1 (en) 1999-01-29 2001-05-08 Andy Wolff Device and method for stimulating salivation
US20050037065A1 (en) * 1999-05-27 2005-02-17 Drugtech Corporation Nutritional formulations
AU5139600A (en) * 1999-05-27 2000-12-18 Drugtech Corporation Nutritional formulations
KR100982753B1 (ko) * 2001-04-05 2010-09-16 콜라제넥스 파마슈티칼스, 인크 테트라사이클린 화합물 및 테트라사이클린 유도체의 전달조절
CA2470636A1 (en) * 2001-12-20 2003-07-03 Pharmacia Corporation Zero-order sustained released dosage forms and method of making the same
US6958161B2 (en) * 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
AUPS167602A0 (en) * 2002-04-12 2002-05-16 F.H. Faulding & Co. Limited An improved modified release preparation
AU2003213876B2 (en) * 2002-04-12 2006-10-12 Mayne Pharma International Pty Ltd An improved modified release preparation
AU2003284942A1 (en) * 2002-10-30 2004-06-07 Pharmacia Corporation Oral extended release tablets and methods of making and using the same
US20040158194A1 (en) * 2003-02-06 2004-08-12 Wolff Andy And Beiski Ben Z. Oral devices and methods for controlled drug release
US7749532B2 (en) * 2003-04-07 2010-07-06 Supernus Pharmaceuticals, Inc. Once daily formulations of tetracyclines
GB2414668B (en) * 2004-06-03 2009-07-29 Dexcel Ltd Tetracycline modified release delivery system
CN101128206A (zh) * 2005-01-21 2008-02-20 沃纳奇尔科特公司 固体剂型形式的四环素类金属络合物
KR101430759B1 (ko) * 2005-02-04 2014-08-19 필립모리스 프로덕츠 에스.에이. 셀룰로오스 풍미 첨가물을 갖는 궐련 및 필터
US20070106138A1 (en) * 2005-05-26 2007-05-10 Beiski Ben Z Intraoral apparatus for non-invasive blood and saliva monitoring & sensing
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US9192615B2 (en) * 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
AU2006331688A1 (en) * 2005-12-22 2007-07-05 Wyeth Oral formulations comprising tigecycline
US20070166273A1 (en) * 2006-01-19 2007-07-19 Krivulka Joseph J Skin treatment educational kit
JP5527921B2 (ja) * 2006-12-22 2014-06-25 エスエス製薬株式会社 苦味を隠蔽した経口固形組成物
ITMI20070022A1 (it) 2007-01-09 2008-07-10 I P S Internat Products & Services Srl Formulazione di prodotti solidi a rilascio controllato per uso orale in bustine monodose e relativo procedimento di preparazione
JP5395052B2 (ja) * 2007-03-23 2014-01-22 モレキュラー リサーチ センター インコーポレイテッド 炎症を処置するための組成物および方法
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
PT2271348T (pt) * 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
JP6077555B2 (ja) * 2012-02-15 2017-02-08 武田薬品工業株式会社 錠剤
EA201992382A3 (ru) 2013-03-15 2020-05-31 Брейнтри Лабораторис, Инк. Пероральная таблетированная фармацевтическая композиция двойного применения на основе сульфатных солей и способы ее применения
US20170182070A1 (en) 2014-10-08 2017-06-29 Mayne Pharma International Pty Ltd. Controlled Release Doxycycline
WO2016162754A1 (en) 2015-04-07 2016-10-13 Dr. Reddy's Laboratories Ltd. Pharmaceutical compositions for minocycline

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148212A (en) * 1961-12-22 1964-09-08 American Cyanamid Co Reductive alkylation process
USRE26253E (en) * 1963-05-17 1967-08-15 And z-alkylamino-g-deoxytetracycline
US3356571A (en) * 1964-11-25 1967-12-05 American Cyanamid Co Potentiation of tetracycline by polyacrylic acid or hydrolyzed polyacrylonitrile
CH434571A (de) * 1966-07-05 1967-04-30 Chemical And Pharmaceutical Pa Verfahren zur Herstellung von Antibiotika mit verlängerter therapeutischer Wirkung
CH434240A (de) * 1965-12-30 1967-04-30 Chemical And Pharmaceutical Pa Verfahren zur Herstellung einer therapeutischen Tetracyclinzubereitung mit verlängerter therapeutischer Wirkung
FR1586811A (no) * 1966-01-06 1970-03-06
US4207258A (en) * 1972-02-24 1980-06-10 Ankerfarm S.P.A. Process for the preparatin of α-6-deoxytetracyclines
FR2183546B1 (no) * 1972-05-10 1975-06-20 Servier Lab
US4038315A (en) * 1972-05-11 1977-07-26 American Cyanamid Company Isolation and recovery of calcium chloride complex of 7-dimethylamino-6-dimethyl l-6-deoxytetracycline hydrochloride
CH582002A5 (no) * 1972-06-09 1976-11-30 Purdue Research Foundation
CA999855A (en) * 1972-09-18 1976-11-16 Societa' Farmaceutici Italia S.P.A. Process for the preparation of tetracyclines derivatives in the 7 position
JPS4941522A (no) * 1973-05-17 1974-04-18
GB1413186A (en) * 1973-06-27 1975-11-12 Toyo Jozo Kk Process for encapsulation of medicaments
US4088798A (en) * 1975-11-11 1978-05-09 Sandoz, Inc. Methods for the preparation of controlled gastric residence time medicament formulations
US4154827A (en) * 1977-12-15 1979-05-15 University Of Pennsylvania Inhibition of ADH-stimulated osmotic water flow and aldosterone-stimulated sodium transport
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4622244A (en) * 1979-09-04 1986-11-11 The Washington University Process for preparation of microcapsules
ES8307096A1 (es) * 1981-06-01 1983-07-01 Orion Yhtymae Oy "un metodo para preparar tabletas a base de polvos de medicamento acidicos, inocuas para el esofago".
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4500458A (en) * 1982-01-19 1985-02-19 Plurichemie Anstalt Process for the preparation of α-6-deoxytetracyclines
US4701320A (en) * 1984-11-29 1987-10-20 Lederle (Japan), Ltd. Composition stably containing minocycline for treating periodontal diseases

Also Published As

Publication number Publication date
PL275089A1 (en) 1989-07-10
CZ656388A3 (en) 1995-02-15
US4837030A (en) 1989-06-06
AU609525B2 (en) 1991-05-02
JPH01128929A (ja) 1989-05-22
IL87699A (en) 1994-06-24
NZ226396A (en) 1991-08-27
AR243077A1 (es) 1993-07-30
DE3853566D1 (de) 1995-05-18
HK1000313A1 (en) 1998-02-27
PT88664B (pt) 2003-06-30
CZ279809B6 (cs) 1995-07-12
KR890006242A (ko) 1989-06-12
HU202110B (en) 1991-02-28
ATE120957T1 (de) 1995-04-15
DK556788D0 (da) 1988-10-05
ZA887478B (en) 1989-06-28
IL87699A0 (en) 1989-02-28
EP0310814A3 (en) 1989-05-03
PH27236A (en) 1993-05-04
ES2070837T3 (es) 1995-06-16
PT88664A (pt) 1989-07-31
EP0310814A2 (en) 1989-04-12
DK175578B1 (da) 2004-12-13
NO175619B (no) 1994-08-01
NO884408D0 (no) 1988-10-05
AU2344488A (en) 1989-04-06
SK656388A3 (en) 1997-10-08
FI97862B (fi) 1996-11-29
CA1338439C (en) 1996-07-09
FI884575A0 (fi) 1988-10-05
DK556788A (da) 1989-04-07
GR3015767T3 (en) 1995-07-31
NO884408L (no) 1989-04-07
DE3853566T2 (de) 1996-01-11
HUT50046A (en) 1989-12-28
FI97862C (fi) 1997-03-10
FI884575A (fi) 1989-04-07
EP0310814B1 (en) 1995-04-12
SK278567B6 (en) 1997-10-08
KR970007902B1 (ko) 1997-05-17
JP2771189B2 (ja) 1998-07-02

Similar Documents

Publication Publication Date Title
NO175619C (no) Fremgangsmåte ved fremstilling av kontrollerte frigjöringsformuleringer av tetracyklinforbindelser
KR960013701B1 (en) Process for preparation of controlled release formulations
GR880100491A (en) Method for the preparation of aketaminophane formulations orally slowly released
PT83756A (en) Process for the manufacture of controlled release pharmaceutical compositions
EG18398A (en) Process for preparing of piperazinyl-heterocyclic compounds
NO943093D0 (no) Fremgangsmåte for fremstilling av clavulansyre
EP0296341A3 (en) Process for the preparation of polyglycerines
KR950013106B1 (en) Process for the preparation of malonic acid derivative compounds
NO173732C (no) Analogifremgangsmaate for fremstilling av 2-arylsubstituerte N- acetyltryptaminer
NO167912C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aromatiske forbindelser
NO173506C (no) Fremgangsmaate ved fremtilling av disvovelanaloger av ll-E33288-antitumormidler
FI881064A (fi) Menetelmä tulehduksenvastaisten tai analgeettisten -aminoetyylisubstituoitujen fenyyliyhdisteiden valmistamiseksi
HU901593D0 (en) Process for the preparation of novel compounds
PT86644A (pt) Process for the preparation of dry formulations containing a salt of diclofenac
NO930183D0 (no) Fremgagsmaate for fremstilling av et komposittprodukt ved stoeping
NO178027C (no) Analogifremgangsmåte ved fremstilling av forlöpere for anti-inflammatoriske 3-acyl-2-oksindol-1-karboksamider
PT87643A (pt) Process for the preparation of pyran compounds
NO178883C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat for behandling av tonsillitt
NO176565C (no) Analogifremgangsmåte for fremstilling av antitrombotisk aktive forbindelser
HU901300D0 (en) Process for preparation of new alpha-lactam compounds
NO177307C (no) Fremgangsmåte for fremstilling av 2-diazo-3-trisubstituerte silyloksy-3-butenoatestere
ZA909346B (en) Process for the preparation of alkylene-bis(2-pyridylamine)compounds
PT88465A (pt) Process for the preparation of macrolide compounds
IE883011L (en) Novel controlled release formulations of tetracycline compounds
NO921423L (no) Fremgangsmaate for fremstilling av deuterobenzaldehyd forbindelser

Legal Events

Date Code Title Description
MK1K Patent expired